LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 68

Search options

  1. Article ; Online: Recent Approaches and Strategies in the Generation of Anti-human Cytomegalovirus Vaccines.

    Boppana, Suresh B / Britt, William J

    Methods in molecular biology (Clifton, N.J.)

    2021  Volume 2244, Page(s) 403–463

    Abstract: Human cytomegalovirus is the largest human herpesvirus and shares many core features of other herpesviruses such as tightly regulated gene expression during genome replication and latency as well as the establishment of lifelong persistence following ... ...

    Abstract Human cytomegalovirus is the largest human herpesvirus and shares many core features of other herpesviruses such as tightly regulated gene expression during genome replication and latency as well as the establishment of lifelong persistence following infection. In contrast to stereotypic clinical syndromes associated with alpha-herpesvirus infections, almost all primary HCMV infections are asymptomatic and acquired early in life in most populations in the world. Although asymptomatic in most individuals, HCMV is a major cause of disease in hosts with deficits in adaptive and innate immunity such as infants who are infected in utero and allograft recipients following transplantation. Congenital HCMV is a commonly acquired infection in the developing fetus that can result in a number of neurodevelopmental abnormalities. Similarly, HCMV is a major cause of disease in allograft recipients in the immediate and late posttransplant period and is thought to be a major contributor to chronic allograft rejection. Even though HCMV induces robust innate and adaptive immune responses, it also encodes a vast array of immune evasion functions that are thought aid in its persistence. Immune correlates of protective immunity that prevent or modify intrauterine HCMV infection remain incompletely defined but are thought to consist primarily of adaptive responses in the pregnant mother, thus making congenital HCMV a potentially vaccine modifiable disease. Similarly, HCMV infection in allograft recipients is often more severe in recipients without preexisting adaptive immunity to HCMV. Thus, there has been a considerable effort to modify HCMV specific immunity in transplant recipient either through active immunization or passive transfer of adaptive effector functions. Although efforts to develop an efficacious vaccine and/or passive immunotherapy to limit HCMV disease have been underway for nearly six decades, most have met with limited success at best. In contrast to previous efforts, current HCMV vaccine development has relied on observations of unique properties of HCMV in hopes of reproducing immune responses that at a minimum will be similar to that following natural infection. However, more recent findings have suggested that immunity following naturally acquired HCMV infection may have limited protective activity and almost certainly, is not sterilizing. Such observations suggest that either the induction of natural immunity must be specifically tailored to generate protective activity or alternatively, that providing targeted passive immunity to susceptible populations could be prove to be more efficacious.
    MeSH term(s) Adaptive Immunity/immunology ; Antibodies, Viral/immunology ; Cytomegalovirus/genetics ; Cytomegalovirus/immunology ; Cytomegalovirus Infections/immunology ; Cytomegalovirus Infections/prevention & control ; Cytomegalovirus Vaccines/immunology ; Disease Susceptibility ; Female ; Humans ; Immunity, Humoral/immunology ; Immunity, Innate/immunology ; Infant ; Male ; Pregnancy ; Vaccination/methods ; Vaccines/immunology ; Vaccines/metabolism ; Vaccines/pharmacology
    Chemical Substances Antibodies, Viral ; Cytomegalovirus Vaccines ; Vaccines
    Language English
    Publishing date 2021-02-09
    Publishing country United States
    Document type Journal Article
    ISSN 1940-6029
    ISSN (online) 1940-6029
    DOI 10.1007/978-1-0716-1111-1_19
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Increasing Prevalence of Pediatric Community-acquired UTI by Extended Spectrum β-Lactamase-producing E. coli: Cause for Concern.

    Collingwood, Joshua D / Yarbrough, April H / Boppana, Suresh B / Dangle, Pankaj P

    The Pediatric infectious disease journal

    2022  Volume 42, Issue 2, Page(s) 106–109

    Abstract: Background: Antimicrobial resistance and emerging spectrum-β-lactamase (ESBL) infections are a rising concern in public health. Despite the increasing prevalence of community-acquired (CA) ESBL-E. coli UTIs, there is little data on the antibiotic ... ...

    Abstract Background: Antimicrobial resistance and emerging spectrum-β-lactamase (ESBL) infections are a rising concern in public health. Despite the increasing prevalence of community-acquired (CA) ESBL-E. coli UTIs, there is little data on the antibiotic resistance profiles of this bacterial strain in the pediatric population. We review antibiotic resistance profile and rising trend in pediatric ESBL-E. coli UTI presentation at our pediatric hospital.
    Methods: This retrospective study reviewed data drawn from the infectious disease database at our pediatric hospital for all patients whose urine culture grew ESBL-E. coli from 01/2015 to 01/2021. Demographic information and antimicrobial susceptibility test results for ESBL-E. coli isolates from CA-UTIs were collected. Annual changes in resistance to antimicrobial agents and average annual percent change in ESBL-E. coli UTI presentation over the study period are reported.
    Results: From 01/2015 to 01/2021, 6403 urine cultures at our hospital grew E. coli. Of these, 169 urine cultures from 135 children grew ESBL-E. coli. The study population was 57% male (77) with a mean age of 6.9 ± 6.2 years and multiethnic. CA-UTI by ESBL-producing E. coli accounted for 2.62% of total E. coli UTIs within the study period and increased from 0.97% in 2015 to 3.54% in 2020 by an average of 0.51% each year.
    Conclusions: These findings demonstrate an increase in CA-ESBL E. coli UTIs in children. We observed most isolates demonstrated multidrug resistance. As CA-ESBL E. coli UTIs are associated with prolonged hospitalization and increased morbidity, our findings highlight the rising trend in pediatric CA-ESBL E. coli UTI.
    MeSH term(s) Humans ; Child ; Male ; Infant ; Child, Preschool ; Adolescent ; Female ; Escherichia coli ; Escherichia coli Infections/epidemiology ; Escherichia coli Infections/drug therapy ; Retrospective Studies ; Prevalence ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Community-Acquired Infections/microbiology ; Urinary Tract Infections/microbiology ; beta-Lactamases ; Anti-Infective Agents
    Chemical Substances Anti-Bacterial Agents ; beta-Lactamases (EC 3.5.2.6) ; Anti-Infective Agents
    Language English
    Publishing date 2022-11-15
    Publishing country United States
    Document type Review ; Journal Article
    ZDB-ID 392481-6
    ISSN 1532-0987 ; 0891-3668
    ISSN (online) 1532-0987
    ISSN 0891-3668
    DOI 10.1097/INF.0000000000003777
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Coronavirus Disease 2019 and Children.

    Boppana, Suresh B / Pinninti, Swetha G / Britt, William J

    The Journal of infectious diseases

    2021  Volume 224, Issue 11, Page(s) 1807–1809

    MeSH term(s) COVID-19 ; Child ; Humans ; SARS-CoV-2
    Language English
    Publishing date 2021-10-13
    Publishing country United States
    Document type Editorial ; Research Support, N.I.H., Extramural ; Comment
    ZDB-ID 3019-3
    ISSN 1537-6613 ; 0022-1899
    ISSN (online) 1537-6613
    ISSN 0022-1899
    DOI 10.1093/infdis/jiab511
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Congenital cytomegalovirus infection.

    Fowler, Karen B / Boppana, Suresh B

    Seminars in perinatology

    2018  Volume 42, Issue 3, Page(s) 149–154

    Abstract: Each year, thousands of children are born with or develop permanent disabilities such as hearing loss, vision loss, motor and cognitive deficits from congenital CMV infection (cCMV). However, awareness of cCMV and its associated sequelae is very low in ... ...

    Abstract Each year, thousands of children are born with or develop permanent disabilities such as hearing loss, vision loss, motor and cognitive deficits from congenital CMV infection (cCMV). However, awareness of cCMV and its associated sequelae is very low in pregnant women and healthcare providers. Both targeted and universal approaches to screen newborns for CMV infection are now achievable due to recent scientific advances including the development of a rapid, high-throughput method for detecting CMV in saliva, the efficacy of antiviral treatment in symptomatic infants, and the demonstration of cost effectiveness of CMV screening. Future studies are needed to address gaps in our understanding on the role of non-primary maternal CMV infections, the evaluation of antiviral treatment in asymptomatic infants, and the implementation of prevention strategies for cCMV.
    MeSH term(s) Antiviral Agents/therapeutic use ; Cognitive Dysfunction/etiology ; Cost-Benefit Analysis ; Cytomegalovirus Infections/complications ; Cytomegalovirus Infections/congenital ; Cytomegalovirus Infections/diagnosis ; Cytomegalovirus Infections/drug therapy ; Female ; Hearing Loss, Sensorineural/etiology ; Humans ; Infant, Newborn ; Mass Screening ; Neonatal Screening ; Pregnancy ; Pregnancy Complications, Infectious ; Saliva ; Vision Disorders/etiology
    Chemical Substances Antiviral Agents
    Language English
    Publishing date 2018-03-02
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 752403-1
    ISSN 1558-075X ; 0146-0005
    ISSN (online) 1558-075X
    ISSN 0146-0005
    DOI 10.1053/j.semperi.2018.02.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Vaccination against the human cytomegalovirus.

    Plotkin, Stanley A / Boppana, Suresh B

    Vaccine

    2018  Volume 37, Issue 50, Page(s) 7437–7442

    Abstract: The human cytomegalovirus (HCMV) is the most important infectious cause of congenital abnormalities and also of infectious complications of transplantation. The biology of the infection is complex and acquired immunity does not always prevent reinfection. ...

    Abstract The human cytomegalovirus (HCMV) is the most important infectious cause of congenital abnormalities and also of infectious complications of transplantation. The biology of the infection is complex and acquired immunity does not always prevent reinfection. Nevertheless, vaccine development is far advanced, with numerous candidate vaccines being tested, both live and inactivated. This article summarizes the status of the candidate vaccines.
    MeSH term(s) Adaptive Immunity ; Antibodies, Neutralizing/blood ; Antibodies, Viral/blood ; Cytomegalovirus/drug effects ; Cytomegalovirus/immunology ; Cytomegalovirus/pathogenicity ; Cytomegalovirus Infections/epidemiology ; Cytomegalovirus Infections/prevention & control ; Cytomegalovirus Infections/transmission ; Cytomegalovirus Infections/virology ; Cytomegalovirus Vaccines/administration & dosage ; Cytomegalovirus Vaccines/biosynthesis ; Developed Countries ; Developing Countries ; Female ; Humans ; Infant, Newborn ; Infectious Disease Transmission, Vertical/prevention & control ; Infectious Disease Transmission, Vertical/statistics & numerical data ; Organ Transplantation/adverse effects ; Prevalence ; Vaccination/methods ; Vaccines, Attenuated ; Vaccines, Live, Unattenuated
    Chemical Substances Antibodies, Neutralizing ; Antibodies, Viral ; Cytomegalovirus Vaccines ; Vaccines, Attenuated ; Vaccines, Live, Unattenuated
    Language English
    Publishing date 2018-04-03
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 605674-x
    ISSN 1873-2518 ; 0264-410X
    ISSN (online) 1873-2518
    ISSN 0264-410X
    DOI 10.1016/j.vaccine.2018.02.089
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Insight Into Long-term Neurodevelopmental Outcomes in Asymptomatic Congenital CMV Infection.

    Boppana, Suresh B / Fowler, Karen B

    Pediatrics

    2017  Volume 140, Issue 5

    MeSH term(s) Cytomegalovirus ; Cytomegalovirus Infections/congenital ; Humans ; Problem Solving
    Language English
    Publishing date 2017
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 207677-9
    ISSN 1098-4275 ; 0031-4005
    ISSN (online) 1098-4275
    ISSN 0031-4005
    DOI 10.1542/peds.2017-2526
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Vaccination against the human cytomegalovirus

    Plotkin, Stanley A / Boppana, Suresh B

    Vaccine. 2019 Nov. 28, v. 37, no. 50

    2019  

    Abstract: The human cytomegalovirus (HCMV) is the most important infectious cause of congenital abnormalities and also of infectious complications of transplantation. The biology of the infection is complex and acquired immunity does not always prevent reinfection. ...

    Abstract The human cytomegalovirus (HCMV) is the most important infectious cause of congenital abnormalities and also of infectious complications of transplantation. The biology of the infection is complex and acquired immunity does not always prevent reinfection. Nevertheless, vaccine development is far advanced, with numerous candidate vaccines being tested, both live and inactivated. This article summarizes the status of the candidate vaccines.
    Keywords Human betaherpesvirus 5 ; adaptive immunity ; congenital abnormalities ; vaccination ; vaccine development ; vaccines
    Language English
    Dates of publication 2019-1128
    Size p. 7437-7442.
    Publishing place Elsevier Ltd
    Document type Article
    ZDB-ID 605674-x
    ISSN 1873-2518 ; 0264-410X
    ISSN (online) 1873-2518
    ISSN 0264-410X
    DOI 10.1016/j.vaccine.2018.02.089
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  8. Article ; Online: Invasive Disease Caused by Haemophilus influenzae Type A.

    Konduri, Anusha / Wolf, Andrea / Boppana, Suresh B

    Clinical pediatrics

    2019  Volume 58, Issue 4, Page(s) 470–473

    MeSH term(s) Anti-Bacterial Agents/therapeutic use ; Diagnosis, Differential ; Female ; Haemophilus Infections/diagnosis ; Haemophilus Infections/drug therapy ; Haemophilus Infections/virology ; Haemophilus influenzae ; Humans ; Infant ; Magnetic Resonance Imaging ; Male ; Spinal Puncture
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2019-01-02
    Publishing country United States
    Document type Case Reports ; Journal Article
    ZDB-ID 207678-0
    ISSN 1938-2707 ; 0009-9228
    ISSN (online) 1938-2707
    ISSN 0009-9228
    DOI 10.1177/0009922818821887
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Higher Expectations for a Vaccine To Prevent Congenital Cytomegalovirus Infection.

    Gantt, Soren / Marchant, Arnaud / Boppana, Suresh B

    Journal of virology

    2018  Volume 92, Issue 15

    MeSH term(s) Cytomegalovirus/immunology ; Cytomegalovirus Infections ; Cytomegalovirus Vaccines ; Humans ; Infectious Disease Transmission, Vertical ; Pregnancy Complications, Infectious ; Vaccines
    Chemical Substances Cytomegalovirus Vaccines ; Vaccines
    Language English
    Publishing date 2018-07-17
    Publishing country United States
    Document type Letter ; Comment
    ZDB-ID 80174-4
    ISSN 1098-5514 ; 0022-538X
    ISSN (online) 1098-5514
    ISSN 0022-538X
    DOI 10.1128/JVI.00764-18
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Risk factors for community acquired pediatric urinary tract infection with extended-spectrum-β-lactamase Escherichia coli - A case-control study.

    Collingwood, Joshua D / Wang, Lingling / Aban, Inmaculada B / Yarbrough, April H / Boppana, Suresh B / Dangle, Pankaj P

    Journal of pediatric urology

    2022  Volume 19, Issue 1, Page(s) 129.e1–129.e7

    Abstract: Introduction: Community-acquired (CA) infections caused by extended-spectrum β-lactamase (ESBL) producing Escherichia coli urinary tract infections (UTI) have become increasingly prevalent, posing a serious threat to public health. Risk factors for ESBL ...

    Abstract Introduction: Community-acquired (CA) infections caused by extended-spectrum β-lactamase (ESBL) producing Escherichia coli urinary tract infections (UTI) have become increasingly prevalent, posing a serious threat to public health. Risk factors for ESBL UTI have not been extensively studied in the pediatric population. We report findings from a case control study to identify risk factors for CA ESBL-producing E. coli UTI in children.
    Materials and method: A cohort of children with CA ESBL Escherichia coli UTI evaluated at a tertiary referral hospital from January 2014 through April 2021, were matched 1:3 with control group of non-ESBL CA E. coli UTI based on age at first episode of non-ESBL UTI. To identify potential risk factors for ESBL E. coli UTI, conditional logistic regression model was utilized accounting for age matching. Univariate models were fitted for each clinical risk factor. Factors found to be significantly associated with ESBL UTI were simultaneously included in a single model to check for associations adjusted for all other factors.
    Results: On conditional multivariate analyses for univariate testing, male sex (P = 0.021), history of Urology care (P = 0.001), and antibiotic treatment within 30 days prior to positive culture (P = 0.004) were identified as independent risk factors for CA ESBL E. coli UTI. Comorbidity scores were assigned to each patient according to pediatric comorbidity index (PCI); children with ESBL UTI were more likely to have higher morbidity risk than non-ESBL UTI children (P < 0.001). From the logistic model, the higher the morbidity scores, the more likely children will have CA ESBL UTI (P < 0.001).
    Discussion: Identifying risk factors for ESBL-producing E. coli UTI in children is important because of limited therapeutic options. This knowledge is essential for clinical decision making and to develop intervention strategies to reduce disease burden. Our study found that although females have an increased predisposition to UTIs, we observed that the male sex is an independent risk factor for ESBL E. coli UTI. This finding warrants further investigation to determine underlying cause. Because of the retrospective design of the study, collection of data from a single center, and differences in characteristics between patient populations, treatments, and prescribing patterns in the community, this study may not be generalizable.
    Conclusions: Findings from our case-control study suggest that the male sex, history of Urology care, and previous antibiotic exposure are independent risk factors for CA ESBL-GNB UTI. Children with ESBL E. coli UTI are more likely to have longer admission duration and higher comorbidity index.
    MeSH term(s) Female ; Child ; Humans ; Male ; Escherichia coli ; Case-Control Studies ; Retrospective Studies ; beta-Lactamases ; Risk Factors ; Escherichia coli Infections/epidemiology ; Escherichia coli Infections/drug therapy ; Community-Acquired Infections/epidemiology ; Community-Acquired Infections/drug therapy ; Urinary Tract Infections/drug therapy ; Urinary Tract Infections/epidemiology ; Anti-Bacterial Agents/therapeutic use
    Chemical Substances beta-Lactamases (EC 3.5.2.6) ; Anti-Bacterial Agents
    Language English
    Publishing date 2022-10-18
    Publishing country England
    Document type Journal Article
    ZDB-ID 2237683-5
    ISSN 1873-4898 ; 1477-5131
    ISSN (online) 1873-4898
    ISSN 1477-5131
    DOI 10.1016/j.jpurol.2022.10.020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top